ET-MF

Clinical trials for ET-MF explained in plain language.

Never miss a new study

Get alerted when new ET-MF trials appear

Sign up with your email to follow new studies for ET-MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can an arthritis drug tame a rare bone marrow cancer?

Disease control Ongoing

This phase 2 trial tests canakinumab, an anti-inflammatory drug, in 14 to 26 people with myelofibrosis, a rare bone marrow cancer that causes scarring, enlarged spleen, and fatigue. Participants receive injections every three weeks for about six months. The study checks if the dr…

Matched conditions: ET-MF

Phase: PHASE2 • Sponsor: John Mascarenhas • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

ET-MF

Get alerted when new ET-MF trials appear

Can an arthritis drug tame a rare bone marrow cancer?